Pumps and Water Treatment Q2 FY2026: AI orders lift Ebara as Organo profit slips
Companies compared · 2

Ebara
6361

Organo
6368
Takeaway
Order momentum and profit growth diverged.
Pump and water-treatment makers Ebara and Organo reported Q2 FY2026 results as AI-chip demand drove orders. Ebara posted record interim orders and higher profit, while Organo's orders surged but operating profit fell. Their reporting periods differ: six months for Ebara, three for Organo.
Industry Overview
AI-related semiconductor investment is a tailwind for both companies. New chip fabs and capacity expansions are driving orders for water-treatment equipment and other systems.
- Ebara's orders rose 41.0% from a year earlier, led by growth in its Precision and Electronics business, setting a record for a first half.
- Organo's orders jumped 85.0%, with major semiconductor-related projects secured in Taiwan, the U.S., Japan and China.
- Orders grew faster than sales at both companies. The time it takes for new orders to convert into revenue will be key to future results.
- The reporting periods differ: Ebara reported six-month interim results, while Organo reported its first quarter. Revenue and operating profit cannot be compared directly by amount.
Revenue Ranking
Ebara reported higher revenue in absolute terms. But its figures cover the first half, while Organo's cover the first quarter, so the difference in reporting periods should be considered when comparing scale.
Operating Profit Ranking
Ebara's operating profit was higher in absolute terms, though the comparison spans six months for Ebara and three months for Organo. Profit growth diverged, with Ebara posting an increase and Organo a decline.
Operating Margin Ranking
Organo's operating margin was higher than Ebara's. However, Organo's operating profit fell despite higher revenue, so changes in profitability matter as much as the margin level.
Winner and Loser
Ebara had the edge in profit growth. First-half revenue rose 9.4% to ¥490.8 billion. Operating profit increased 1.2% to ¥50.7 billion, while net profit gained 7.1% to ¥33.6 billion.
Organo's first-quarter revenue rose 10.7% to ¥42.2 billion. Operating profit, however, fell 4.9% to ¥6.6 billion, and net profit declined 5.7% to ¥3.4 billion. Sales growth outpaced Ebara's, but profit fell.
Organo's operating margin of 15.7% exceeded Ebara's 10.3%. But a lower gross margin and higher fixed costs weighed on Organo's earnings. Ebara's margin also fell, from 11.2% a year earlier. Organo led in order momentum, while Ebara came out ahead in near-term profit growth.
Winner
Ebara
Laggard
Organo
Strategy and Key Developments
Ebara capitalized on AI-related semiconductor demand through its Precision and Electronics business. As orders expanded, it raised its full-year forecasts for orders and revenue. A shift to a loss in its Energy business, however, restrained profit growth.
Organo stood out for winning large semiconductor projects. Following the surge in orders, it raised its full-year order forecast by 30.4%. Its full-year forecasts are ¥200 billion in revenue and ¥40 billion in operating profit.
For both companies, the next test is turning orders into sales and earnings. Ebara must address differences in profitability across its businesses, while Organo faces the challenge of controlling costs as orders grow.
Common Industry Risks
- A slowdown in AI-related capital spending could reduce semiconductor-related orders. The more orders are concentrated in this area, the greater the exposure to swings in demand.
- Delays in delivery or customer acceptance of large projects can shift the timing of revenue recognition. A bigger order backlog does not guarantee immediate profits.
- Rising materials and labor costs can squeeze margins. Organo's operating profit fell despite higher revenue, putting the focus on its ability to sustain profitability.
- Foreign exchange movements and the economics of overseas projects can also affect results. Currency gains lifted Organo's ordinary profit, but exchange-rate moves can have the opposite effect.
- Tighter water-quality and environmental regulations may create demand for equipment while also increasing compliance costs.
Ranking Shifts and Structural Trends
Ebara's revenue and operating profit were higher in absolute terms than Organo's, but Ebara's figures cover six months and Organo's cover three. The ranking reflects not only differences in business scale but also the different reporting periods.
Organo's revenue growth of 10.7% exceeded Ebara's 9.4%. Organo led in order growth, while Ebara was stronger in profit performance. The gap between order growth and profit growth makes project margins and the speed of converting orders into sales key factors in future competitiveness.
For Job Seekers and Career Changers
The expansion of semiconductor fabs is creating work in the design, construction and maintenance of pumps and ultrapure water systems. Overseas projects are also plentiful, creating opportunities not only for engineers but also in sales and project management.
More orders do not necessarily mean profits will rise immediately. Managing schedules and costs on large projects is also critical. When weighing employers, candidates should look beyond growth sectors to the stability of earnings across business lines and the share of work tied to overseas projects.
Year-on-Year Revenue Growth
Both companies delivered strong revenue growth, with Organo narrowly ahead. AI semiconductor-related equipment demand supported both, though their reporting periods differ.
Year-on-Year Net Profit Growth
Ebara's net profit increased, while Organo's declined. The results show that a surge in orders did not translate into profits in the same way at both companies.
